Eligo Bioscience (France)

Eligo Bioscience is deploying in vivo gene editing technologies against microbiome targets to address diseases with high unmet needs.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Eligo Bioscience (France).

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Eligo Bioscience is deploying in vivo gene editing technologies against microbiome targets to address diseases with high unmet needs.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.